Momeclir Use In Pregnancy & Lactation

Concise Prescribing Info Full Prescribing Info Contents Description Action Indications/Uses Dosage/Direction for Use Contraindications Special Precautions Use In Pregnancy & Lactation Adverse Reactions Drug Interactions Storage MIMS Class ATC Classification Regulatory Classification Presentation/Packing

Full Prescribing Info

Use In Pregnancy & Lactation

There are no adequate or well-controlled studies in pregnant women. Following intranasal administration of the maximal recommended clinical dose, mometasone plasma concentrations are not measurable; thus, fetal exposure is expected to be negligible and the potential for reproductive toxicity, very low. As with other nasal corticosteroid preparations. Mometasone furoate (Momeclir) Nasal spray suspension should not be used in pregnancy or lactation unless the potential benefit to the mother justifies any potential risk to the mother, fetus or infant. Infants born of mothers who received corticosteroids during pregnancy should be observed carefully to hypoadrenalism.

Momeclir Use In Pregnancy & Lactation

mometasone

Manufacturer:

Hanlim Pharma

Distributor:

OEP Phils